U.S. FDA Staff Questions King Pharmaceuticals®, Inc., Acura Pharmaceuticals, Inc. Pain Drug, Acurox

Reuters -- U.S. regulators questioned if an experimental pain drug from King Pharmaceuticals (KG.N) and Acura Pharmaceuticals (ACUR.O) would deter abuse, documents released on Tuesday showed.